The veterinary anti-infective is a broad criterion, wherein the animals are taken care by ensuring both the prevention and curative methods for the disease. There are various infections caused to the animals which are food borne or even Zoonotic diseases. The animal types which are focused in the veterinary anti-infective include the cats, dogs, cattle, poultry and others. Furthermore the several types of drugs which can be used for the treatment of these diseases based on the requirement. The spread of the diseases is also would prevent infectious agents or organisms from spreading. The zoonotic disease affect the human too and hence requires precautionary measures for safety.
COVID-19 scenario analysis:
The COVID-19 impact is affecting the healthcare systems worldwide. Increase in need for healthcare facilities and healthcare workers are being observed in the forecast period. The pandemic cases are observed to be caused because of direct or indirect contact between humans. The animals aren’t proved to be spreading the disease but the pets are getting abandoned in the current scenario. Furthermore, COVID-19 has weakened the supply chain and has created shortage of animal health products such as nutritional feed as well as vaccines. The animal health industry has been impacted negatively, as manufacturers in animal health industry are left with a significantly reduced workforce.
Healthcare facilities are stocking up the animal related health products, considering the high demand. This is anticipated to further create financial strain on the market due to procurement inefficiencies and wasted speeding. Due to the pandemic situation, many hospitals and veterinary clinics are overstocking the products.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
The key factor that is anticipated to boost the industry includes the increase in the incidences of the infectious and zoonotic diseases. The growth in the need for the precautionary measures and the treatment is also expected to help the market propel in the coming years. Furthermore, the increase in R&D activities in animal health tends to help in boosting the industry. The rise in the food borne diseases, which may be caused due to the contamination of food would help in the market growth in the forecast period. The surge in the pet-ownership would help the industry flourish.
New product advancements to flourish the market
In September 2019, Team Vetoquinol India launched Antibiotic Wound dressing spray (Aluspray AWD) in July-2019. This is the product for applying on wound, which acts as protective physical and chemical barrier stopping the infection and keep the dirt and bacteria out while allowing the wound to heal faster. Launch demonstrations were done by Vetoquinol team to Veterinary practitioners across India. The product was also demonstrated to canine practitioners, academicians and progressive dairy farmers. The product is available in two presentations 125 ML for Large animal and 75 ML for Small animal use.
In November 2019, a new consortium of research institutes, universities, not-for-profit organizations, and pharmaceutical companies have teamed up to develop novel drugs for infections caused by parasitic worms (helminthes), a debilitating group of diseases that includes river blindness, lymphatic filariasis as well as infection with hookworm and whipworm, which together affect close to a billion people.
Surge in mergers and acquisitions to boost the market
In May 2018, Zoetis Inc. and Abaxis, Inc. announced a definitive merger agreement pursuant to which Zoetis acquired Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for $83 per share in cash, or approximately $2.0 billion in aggregate. The acquisition is expected to enhance Zoetis’ presence in veterinary diagnostics, a category of the animal health industry with approximately 10% compound annual growth over the last three years.
This acquisition brings Zoetis a company that has a proven, competitive diagnostic platform for growth that we can help to accelerate in the U.S. and worldwide with our global scale and direct customer relationships in approximately 45 countries.
Key benefits of the report:
- This study presents the analytical depiction of the global veterinary anti-infective industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global veterinary anti-infective market share.
- The current market is quantitatively analyzed to highlight the global veterinary anti-infective market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the veterinary anti-infective market.
- The report provides a detailed global veterinary anti-infective market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the veterinary anti-infective market research report:
- Who are the leading market players active in the Veterinary Anti-Infective market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in tasking further strategic steps?
Veterinary Anti-Infective Market Report Highlights
| Aspects | Details |
 By Animal Type |
|
 By Product Type |
|
 By Mode of Administration |
|
 By Region |
|
 Key Market Players | Bayer AG, Cipla Limited, Phibro Animal Health Corporation, Eli Lilly and Company (Elanco Animal Health), Neogen Corporation, Heska Corp (Diamond Animal Health), Sanofi (Merial Animal Health), Merck & Co., Inc. (Merck Animal Health), Dechra Pharmaceuticals PLC, Vetoquinol S.A. |
Loading Table Of Content...
